Timber Hill LLC Sells 2,614 Shares of Walgreens Boots Alliance (WBA)

Timber Hill LLC lowered its stake in Walgreens Boots Alliance (NASDAQ:WBA) by 10.5% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 22,181 shares of the pharmacy operator’s stock after selling 2,614 shares during the period. Timber Hill LLC’s holdings in Walgreens Boots Alliance were worth $1,452,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the stock. Parkside Investments LLC grew its stake in shares of Walgreens Boots Alliance by 3.0% in the 4th quarter. Parkside Investments LLC now owns 24,806 shares of the pharmacy operator’s stock worth $1,801,000 after buying an additional 715 shares during the last quarter. BTIM Corp. boosted its stake in Walgreens Boots Alliance by 3.5% during the 4th quarter. BTIM Corp. now owns 21,457 shares of the pharmacy operator’s stock valued at $1,558,000 after purchasing an additional 725 shares during the last quarter. Eads & Heald Investment Counsel boosted its stake in Walgreens Boots Alliance by 3.6% during the 4th quarter. Eads & Heald Investment Counsel now owns 21,249 shares of the pharmacy operator’s stock valued at $1,543,000 after purchasing an additional 748 shares during the last quarter. 440 Investment Group LLC boosted its stake in Walgreens Boots Alliance by 1.6% during the 4th quarter. 440 Investment Group LLC now owns 49,341 shares of the pharmacy operator’s stock valued at $3,583,000 after purchasing an additional 780 shares during the last quarter. Finally, Carnegie Capital Asset Management LLC boosted its stake in Walgreens Boots Alliance by 3.3% during the 4th quarter. Carnegie Capital Asset Management LLC now owns 24,680 shares of the pharmacy operator’s stock valued at $1,783,000 after purchasing an additional 790 shares during the last quarter. Institutional investors own 61.52% of the company’s stock.

Get Walgreens Boots Alliance alerts:

In related news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Wednesday, May 2nd. The stock was sold at an average price of $65.56, for a total value of $179,372.16. Following the transaction, the director now directly owns 13,679 shares of the company’s stock, valued at approximately $896,795.24. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. 14.80% of the stock is currently owned by company insiders.

WBA has been the topic of several recent analyst reports. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a research note on Saturday, April 7th. Royal Bank of Canada set a $94.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Friday, February 16th. Pivotal Research cut their target price on Walgreens Boots Alliance from $73.00 to $69.00 and set a “hold” rating on the stock in a research note on Friday, March 23rd. ValuEngine downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Finally, BidaskClub downgraded Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Thursday, March 22nd. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and a consensus price target of $83.20.

NASDAQ WBA opened at $65.74 on Thursday. The firm has a market cap of $64.07 billion, a PE ratio of 11.44, a PEG ratio of 1.05 and a beta of 1.15. The company has a current ratio of 0.90, a quick ratio of 0.45 and a debt-to-equity ratio of 0.44. Walgreens Boots Alliance has a 1-year low of $64.88 and a 1-year high of $65.72.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.18. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The firm had revenue of $33.02 billion for the quarter, compared to analysts’ expectations of $32.20 billion. During the same period in the prior year, the firm earned $1.36 EPS. The company’s revenue was up 12.1% compared to the same quarter last year. analysts forecast that Walgreens Boots Alliance will post 5.92 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 12th. Investors of record on Friday, May 18th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Thursday, May 17th. This represents a $1.60 dividend on an annualized basis and a yield of 2.43%. Walgreens Boots Alliance’s dividend payout ratio is currently 31.37%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Leave a Reply

Your email address will not be published. Required fields are marked *